Evidence of a Therapeutic Window for TNF-α Inhibitor and Intravenous Immunoglobulin Benefits in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treatment: A Multicenter 6-Year Retrospective Study
Fields of Study & Subjects
Drug-Induced Adverse Reactions
Blood disorders and treatments
Autoimmune Bullous Skin Diseases
Publication details
- Journal / source
- The Journal of Allergy and Clinical Immunology In Practice
- Publisher
- Elsevier BV
- Volume
- 14
- Issue
- 5
- Pages
- 1087–1093.e3
- Publication date
- 19 January 2026
- Language
- EN